Financhill
Back

Global Blood Therapeutics 10K Form

Buy
51

GBT
Global Blood Therapeutics

Last Price:
68.10
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GBT News And Ratings

See the #1 stock for the next 7 days that we like better than GBT

GBT Financial Statistics

Sales & Book Value

Annual Sales: $194.75M
Cash Flow: $-44.69M
Price / Cash Flow: 0
Annual Sales: $1.76
Price / Book: 38.82

Profitability

EPS (TTM): -5.01000
Net Income (TTM): $-322.46M
Gross Margin: $191.43M
Return on Equity: -150.29%
Return on Assets: -41.32%

Global Blood Therapeutics Earnings Forecast

Key Global Blood Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 5 years for GBT is 98.30%.
  • The Selling, General & Administrative Expenses for GBT have been equal to 137.09% of Gross Profit Margin.
  • The Research & Development expenses have been 108.93% of Revenue.
  • The Interest Expense is -5.10% of Operating Income.
  • The Net Earning history of GBT is -155.63% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 2 years.

Global Blood Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: GBT
CUSIP: 37890U
Website: gbt.com

Debt

Debt-to-Equity Ratio: 4.92
Current Ratio: 6.88
Quick Ratio: 5.88

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GBT Technical Analysis vs Fundamental Analysis

Buy
51
Global Blood Therapeutics (GBT) is a Buy

Is Global Blood Therapeutics a Buy or a Sell?